Table 2. .

Association of HIV Infection With sICAM-1 and sVCAM-1 Adjusted for Demographic, and CVD Risk Factors Plus Markers of Intestinal Barrier Dysfunction and Monocyte Activation

	Fully Adjusteda	Fully Adjusted + I-FABPb	Fully Adjusted + sCD14b
	% Estimate (95% CI)	% Estimate (95% CI)	% Estimate (95% CI)
sICAM-1
HIV-	Reference	Reference	Reference
HIV+	49 (33 to 67)**	42 (26 to 60)**	18 (5 to 33)*
sVCAM-1
HIV-	Reference	Reference	Reference
HIV+	30 (14 to 48)**	23 (8 to 41)*	0 (–13 to 15)

Table 2 shows the results of a multivariable linear regression analysis that assessed the associations between HIV serostatus with sVCAM-1 and sICAM-1. “% Estimate” inidcates percent differences.

Abbreviations: CVD, cardiovascular disease; HDL, high-density lipoprotein; I-FABP, intestinal fatty acid-binding protein; sCD14, cluster of differentiation 14; sICAM-1, soluble intercellular cell adhesion molecule–1; sVCAM-1, soluble vascular cell adhesion molecule–1.

*P < .05; ^**P < .001.

^aThe models are adjusted for age, sex, and CVD risk factors (fasting glucose levels, systolic blood pressure, body mass index, smoking and alcohol consumption status, triglycerides, and HDL cholesterol).

^bThe models are adjusted for age, sex, CVD risk factors, sCD14 or I-FABP.